No predefined specific diseases or conditions
Conditions
Interventions
Group 1: MR-examination. No use of contrast agents.
Sponsors
Siemens AG
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Patients with a clinical indication for an MRT examination - Healthy Volunteers (for protocol optimisation only) - Patients or volunteers, who have been adequately informed and have given their written informed consent for participation in the clinical investigation - Patients and volunteers, aged = 18 years
Exclusion criteria
Exclusion criteria: Patients and volunteers who are participating in another study that requires Ethics Committee approval. Non-interventional studies are permitted. • Patients and volunteers with one or more of the following: o Claustrophobia o Cardiac arrhythmia o Cardiac pacemaker & other active implants o Intrauterine device o Pregnant female patients, and female patients with suspicion of pregnancy o Metal or metal implant in patient’s body • Persons with spasm or seizure disorder • Persons, who are either not adult, not sui juris, or who are institutionalized by court order.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| The secondary objectives are to evaluate clinical workflow, system handling and patient comfort. The evaluation will be performed directly after the examination has been finished by the investigator using a visual analogue scaling. | — |
Primary
| Measure | Time frame |
|---|---|
| The primary objectives are to evaluate image quality, image resolution, diagnostic quality and image acquisition speed. Evaluation will be performed directly after the examination has been finished by the investigator using a visual analogue scaling. | — |
Countries
Germany
Contacts
Public ContactMartina Fichtner
Siemens AG
Outcome results
None listed